Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06208124
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-01-05
Brief Title:
A Study of IMM-6-415 in RASRAF Mutant Solid Tumors
Sponsor:
Immuneering Corporation
Organization:
Immuneering Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor Phase 1 |
| Pancreas Adenocarcinoma |
| Non-small Cell Lung Cancer |
| Malignant Melanoma Cutaneous |
Keywords:
| Name | View |
|---|---|
| V600K | View |
| pan-RAS | View |
| pan-RAF | View |
| KRAS | View |
| NRAS | View |
| HRAS | View |
| BRAF | View |
| targeted therapy | View |
| metastatic therapy | View |
| RAS | View |
| RAF | View |
| adenocarcinoma | View |
| MEK | View |
| dual MEK | View |
| G12A | View |
| G12C | View |
| G12D | View |
| G12F | View |
| G12V | View |
| Q61H | View |
| Q61K | View |
| Q61R | View |
| Q61L | View |
| A146T | View |
| A146V | View |
| K117N | View |
| Mitogen-Activated Protein Kinase MAPK | View |
| V600E | View |